Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study

Author： Vena Gino A.   Galluccio Antonia   Pezza Michele   Vestita Michelangelo   Cassano Nicoletta  

Publisher： Informa Healthcare

ISSN： 1471-1753

Source： Journal of Dermatological Treatment, Vol.23, Iss.4, 2012-08, pp. : 255-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: An immunohistochemical study

By van der Velden Haike M. J.   Pasch Marcel C.   van Erp Piet E. J.   van Lingen Rosanne G.   Otero Marisol E.   de Boer-van Huizen Roelie T.   van de Kerkhof Peter C. M.  

Journal of Dermatological Treatment, Vol. 21, Iss. 1, 2010-01 ,pp. : 13-22

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet®) versus calcipotriol (Daivonex®) in the treatment of psoriasis vulgaris: A randomized, multicentre, clinical trial

By Saraceno Rosita   Andreassi Lucio   Ayala Fablo   Bongiorno Maria Rita   Giannetti Alberto   Lisi Paolo   Martini Patrizia   Peris Ketty   Peserico Andrea   Chimenti Sergio  

Journal of Dermatological Treatment, Vol. 18, Iss. 6, 2007-01 ,pp. : 361-365

Informa Healthcare

Access to resources Recommend Favorite

Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: Effects on T-cell infiltration, epidermal proliferation and keratinization

By Bovenschen Jorn   Erceg Angelina   Van Vlijmen-Willems Ivonne   Van De Kerkhof Peter   Seyger Marieke  

Journal of Dermatological Treatment, Vol. 18, Iss. 1, 2007-01 ,pp. : 32-39

Informa Healthcare

Access to resources Recommend Favorite

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

By Au Shiu-Chung  

Journal of Dermatological Treatment, Vol. 24, Iss. 3, 2013-06 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

0.3% Tacrolimus Gel and 0.5% Tacrolimus Cream Show Efficacy in Mild to Moderate Plaque Psoriasis: Results of a Randomized, Open-label, Observer-blinded Study

By Ortonne Jean-Paul   van de Kerkhof Peter C. M.   Prinz Jörg C.   Bieber Thomas   Lahfa Morad   Rubins Andris   Wozel Gottfried      

Acta Dermato-Venereologica, Vol. 86, Iss. 1, 2006-01 ,pp. : 29-33

Medical Journals Limited

Access to resources Recommend Favorite